Symptoms
Common signs and symptoms of Acute Myeloid Leukemia include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Acute Myeloid Leukemia.
Causes
AML develops when DNA damage occurs in the bone marrow cells responsible for creating blood cells. Think of your bone marrow as a busy factory that normally produces three types of blood cells: red blood cells to carry oxygen, white blood cells to fight infection, and platelets to help with clotting. When certain genes become damaged or mutated, this factory begins mass-producing abnormal white blood cells that don't function properly. Most cases of AML occur sporadically, meaning the DNA damage happens by chance during normal cell division - like a typo that occurs when copying a long document. Scientists haven't identified what triggers this damage in the majority of patients, though they suspect it results from a combination of genetic susceptibility and environmental factors accumulating over time. In some cases, AML develops as a secondary cancer following treatment for other cancers, particularly after exposure to certain chemotherapy drugs or radiation therapy. A small percentage of cases are linked to inherited genetic disorders or previous blood disorders like myelodysplastic syndrome, but most people diagnosed with AML have no family history of blood cancers.
Risk Factors
- Age over 60 years
- Previous cancer treatment with chemotherapy or radiation
- Exposure to high levels of benzene or formaldehyde
- History of blood disorders like myelodysplastic syndrome
- Genetic disorders such as Down syndrome or Li-Fraumeni syndrome
- Heavy smoking, especially long-term use
- Male gender
- Previous treatment for other blood cancers
Diagnosis
How healthcare professionals diagnose Acute Myeloid Leukemia:
- 1
Diagnostic Process
When doctors suspect AML, they typically start with a detailed medical history and physical examination, checking for enlarged lymph nodes, liver, or spleen. Blood tests come next, revealing telltale signs like abnormally low red blood cell and platelet counts, along with either very high or very low white blood cell counts. These initial blood tests often show blast cells - immature white blood cells that shouldn't normally circulate in large numbers. The definitive diagnosis requires a bone marrow biopsy, where a small sample of bone marrow is extracted from the hip bone using a special needle. This procedure, done under local anesthesia, allows pathologists to examine the bone marrow cells under a microscope and determine the exact type of AML. Additional tests include genetic analysis of the cancer cells to identify specific mutations, which helps doctors choose the most effective treatment approach. Imaging studies like CT scans or chest X-rays may be ordered to check for enlarged organs or signs that the leukemia has spread. The entire diagnostic process typically takes several days to a week, during which time doctors may begin supportive care to manage symptoms and prevent complications.
Complications
- The most immediate complications of AML stem from the lack of healthy blood cells circulating in your body.
- Severe anemia can cause dangerous drops in blood pressure and heart problems, while extremely low platelet counts can lead to life-threatening bleeding, particularly in the brain or digestive tract.
- Perhaps most seriously, the shortage of functioning white blood cells leaves patients vulnerable to overwhelming infections that can progress rapidly and become fatal without prompt treatment.
- Treatment itself brings additional challenges, including tumor lysis syndrome, where rapid destruction of cancer cells overwhelms the kidneys and can cause dangerous electrolyte imbalances.
- Long-term survivors may face lasting effects from intensive chemotherapy or radiation, including increased risk of other cancers, heart problems, and fertility issues.
- However, many patients who achieve remission go on to live normal, healthy lives, and advances in supportive care have dramatically reduced treatment-related complications compared to even a decade ago.
Prevention
- Unfortunately, most cases of AML cannot be prevented since they result from random genetic changes that occur naturally over time.
- However, you can reduce your risk by avoiding known environmental triggers when possible.
- This includes limiting exposure to benzene, found in gasoline, industrial solvents, and cigarette smoke, and following safety protocols if you work with chemicals or in industries with potential carcinogen exposure.
- Quitting smoking represents one of the most impactful steps you can take, as tobacco use increases AML risk and worsens treatment outcomes.
- If you're undergoing cancer treatment, discuss the long-term risks of therapy with your oncologist - while the benefits typically far outweigh the risks, understanding your future cancer surveillance needs can help with early detection.
- For those with inherited genetic conditions that increase AML risk, regular monitoring with blood tests allows for early intervention if abnormal cells begin developing.
Treatment
Treatment for AML typically unfolds in two main phases: induction therapy to achieve remission, followed by consolidation therapy to prevent relapse. Induction chemotherapy uses powerful drugs like cytarabine combined with daunorubicin or idarubicin, administered intravenously over several days in the hospital. This intensive treatment aims to destroy leukemia cells and restore normal blood cell production, though it temporarily weakens the immune system and requires careful monitoring for infections. For patients under 60 with good overall health, this approach achieves remission in about 70-80% of cases. Consolidation therapy follows successful induction, using either additional rounds of high-dose chemotherapy or stem cell transplantation. Stem cell transplants, which can use the patient's own cells or cells from a matched donor, offer the best chance for long-term cure in many cases but carry significant risks and require extensive recovery time. The specific treatment plan depends heavily on the patient's age, overall health, and the genetic characteristics of their leukemia cells. Newer targeted therapies are revolutionizing treatment for certain genetic subtypes of AML. Drugs like midostaurin for FLT3-mutated AML and venetoclax for older patients who can't tolerate intensive chemotherapy have shown remarkable results in clinical trials. These precision medicines work by targeting specific vulnerabilities in cancer cells while causing fewer side effects than traditional chemotherapy.
Living With Acute Myeloid Leukemia
Managing life with AML requires building a strong support network and adapting to a new normal that prioritizes your health above all else. During active treatment, you'll likely spend considerable time in the hospital and need help with daily activities like grocery shopping, meal preparation, and transportation to appointments. Many patients find that accepting help from family and friends, while initially difficult, becomes essential for focusing energy on recovery. Infection prevention becomes a critical daily practice, involving frequent handwashing, avoiding crowds during low white blood cell counts, and staying current with recommended vaccinations once your immune system recovers. Practical strategies for managing fatigue include:
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Feb 27, 2026v1.0.1
- Fixed narrative story opening in excerpt
- Excerpt no longer starts with a named-character or scenario opening
Feb 26, 2026v1.1.0
- Updated broken source links
- Replaced or removed 404 dead links
Feb 3, 2026v1.0.0
- Published page overview and treatments by DiseaseDirectory